Democritus University of Thrace (DUTH)
Ρύθμιση κυτταροκινών και ανοσολογική ανταπόκριση - ο ρόλος της πυρίνης και του ASC στην αυτοφλεγμονή
Abstract
dc:descriptionFamilial Mediterranean Fever (FMF) represents the prototype model of autoinflammatory disease. After positonal cloning of the MEFV gene in 1997, the diagnosis of FMF is based on certain mutations besides the established clinical criteria. The mutational spectrum, the carrier frequency and the genotype – phenotype correlation in the Greek region are still unknown. The present study represents the first clinical and genetic description of a large series of patients with FMF in Greece. In order to determine the mutational spectrum of the MEFV gene, 146 patients were analyzed. Mutational analysis was also performed in samples derived from 27 patients with UC. Twenty eight patients with RA, 15 patients with autoimmune conditions and 196 healthy individuals were used as control group. The NIRCA technique was optimized as a first screening method of MEFV. NIRCA constitutes a practical, rapid and low cost method, exhibiting high sensitivity and absolute reliability of analysis, as proven by direct sequencing. Therefore, the diagnostic value of mutational analysis in the full length MEFV sequence is evident, especially in groups of patients with non-ancestral origin where the spectrum and frequency of mutations is unknown. Mutational analysis reveals that FMF is not a rare disease in Greece. A relatively high percentage (14,1%) of the mutations screened by NIRCA were missed by the classic diagnostic approaches, resulting to underdiagnosis. The frequency of the healthy carriers of major MEFV mutations in the Greek population is estimated for the first time to be 1/70 of the total population. Morover, 28% of the patients fulfilling the FMF diagnostic criteria do not carry mutations in MEFV. So we investigated the possible existence of additional genetic defects in the pathogenesis of FMF, inside or outside the coding region of MEFV. The absence of mutations in the MEFV promoter region confirms that FMF is characterized by locus heterogeneity. The probable existence of other mutated genes or additional molecular mechanisms contribute in the disease emergence and regulation of the phenotype severity. The absence of other mutations in the MEFV coding sequence, the favorable response to colchicine and the absence of the defect in healthy individuals and patients with autoimmune conditions raise the possibility that R202Q homozygosity represents a pathogenetic event in FMF. The absence of mutations in the ASC gene confirms its crucial role in the biological pathway of inflammation and rules out a direct involvement in the pathogenesis of FMF. In the last part of the study it was presented that 1/4 of patients with ulcerative uolitis (UC) are carriers of mutations in the MEFV gene. The possibility of disease overlap of UC and FMF has been raised previously, especially in atypical cases. Altered pyrin might cause susceptibility to inflammation, a fact that is confirmed by the modifying effect in diseases related to FMF, such as UC. Finally, it was shown that FMF patients constantly overexpress CIAS1 in neutrophils and lymphocytes. The overexpression of CIAS1 strengthens the hypothesis that mutated pyrin exhibits its proinflammatory action by participating in protein complexes – “inflammasomes”, possibly through the adaptor molecule ASC.
Degree
thesis:*- Grantor dc:publisher
- Democritus University of Thrace (DUTH)
- Year dc:date
- 2005
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Giaglis, Stavros
- Γιαγλής, Σταύρος
Subjects
dc:subject × 15Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/17555